You Position: Home > Paper
Cancer-targeting potential of small interference RNA expression vector containing hTERT/U6 chimeric promoter
( views:171, downloads:1 )
- Author:
- No author available
- Journal Title:
- JOURNAL OF THE FOURTH MILITARY MEDICAL UNIVERSITY
- Issue:
- 9
- DOI:
- 10.3321/j.issn:1000-2790.2008.09.003
- Key Word:
- 端粒酶逆转录酶;启动子;siRNA表达栽体;靶向性
Abstract： 目的:体外研究siRNA-EGFP-hTERT/U6-PTZU6+1表达载体在肿瘤细胞中的靶向性.方法:常规培养稳定表达绿色荧光蛋白的肝癌SMMC-7721细胞株(EGFP-7721)和稳定表达绿色荧光蛋白的人正常成纤维细胞株HELF(EGFP-HELF).以PTZU6+1质粒转染EGFP-7721细胞和EGFP-HELF细胞为空白质粒组,siRNA-EGFP-PTZU6+1质粒转染EGFP-7721细胞和EGFP-HELF细胞为实验对照组,将siRNA-EGFP-hTERT/U6-PTZU6+1质粒转染EGFP-7721细胞和EG-FP-HELF细胞作为实验组,用real-time SYBR Green PCR和Western Blot鉴定siRNA-EGFP-hTERT/U6-PTZU6+1对两种细胞株的绿色荧光蛋白表达的影响.结果:正向和反向的重组质粒siRNA-EGFP-hTERT/U6-PTZU6+1转染EGFP-HELF细胞与空白质粒比较,EGFP基因表达无差异(P>0.05),而转染稳定表达绿色荧光蛋白的7721后仅反向的siRNA-EG-FP-hTERT/U6-FIEU6+1重组质粒抑制EGFP基因的表达(P<001).siRNA-EGFP-PTZU6+1质粒与空白质粒组比较,在EGFP-7721和EGFP-HELF细胞株间,EGFP基因的表达均具有统计学差异(P<0.01).结论:反向插入的siRNA-EGFP-hTERT/U6-PTZU6+1重组质粒在肿瘤细胞具有一定靶向性,为进一步探讨基因的靶向治疗奠定了基础.
- [1]李力人,万德森,潘志忠,等.端粒酶逆转录酶在结肠癌组织中表达的临床意义[J].2004,(z1).
- [2]Gewirtz AM.On future's doorstep: RNA interference and the pharmacopeia of tomorrow.[J].2007,117(12).
- [3]Tanaka N,Urata Y,Fujiwara T.Telomerase-specific oncolytic virotherapy for human cancer with the hTERT promoter.[J].2007,7(2).
- [4]Jin Z,Park F,Lanson NA Jr,etc.Conditional expression of a suicide gene by the telomere reverse transcriptase promoter for potential post-therapeutic deletion of tumorigenesis.[J].2005,96(9).
- [5]Guo W,Wang L,Zhang L,etc.Oncolysis and suppression of tumor growth by a GFP-expressing oncolytic adenovirus controlled by an hTERT and CMV hybrid promoter.[J].2006,13(7).
- [6]Xiang S,Parker A,Li CX,etc.Delivery of RNA interference.[J].2006,5(18).